FURX Key Stats
- 5 Healthcare Stock Earnings Snapshots May 12
- Narrower-than-Expected Loss at ArQule May 9
- FURIEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 9
- Narrower-than-Expected Loss at ArQule - Analyst Blog Zacks May 9
- Furiex Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Tran... May 8
- Furiex Pharmaceuticals Earnings: Here’s Why Investors are Not Happy Now May 7
- Furiex Pharmaceuticals, Inc. (FURX) Tops Q1 EPS by 3c Street Insider May 7
- Furiex Reports First Quarter 2013 Financial Results Business Wire May 7
- Furiex Pharmaceuticals: Here’s What Investors Need to Know Before Earnings May 7
- FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Finan... May 7
FURX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Furiex Pharmaceuticals is up 116.0% over the last year vs S&P 500 Total Return up 27.77%, Advisory Board Company up 4.65%, and ABM Industries up 11.63%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for FURX
Pro Report PDF for FURX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download FURX Pro Report PDF
Pro Strategies Featuring FURX
Did Furiex Pharmaceuticals make it into our Pro Portfolio Strategies?